New EHA 2025 GUIDELINES on the management of large B cell lymphomas - European Medical Journal

New EHA 2025 GUIDELINES on the management of large B cell lymphomas

Hematology
Download PDF

The publication of this infographic was supported by Bristol Myers Squibb.


A 2025 EHA guideline for managing large B-cell lymphoma includes new recommendations for CAR T-cell therapy in patients who relapse within 12 months of 1L treatment. Our infographic summarizes the new guidance and treatment eligibility criteria.

Topics covered include:

  • New EHA recommendations for 1L, 2L and 3L treatment of LBCL
  • How to stratify patients for 2L CAR T.
  • Recommendations for diagnosis and disease monitoring.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.